243.80p-1.20 (-0.49%)05 Nov 2025, 09:05
Jump to:
Convatec Group PLC Fundamentals
| Company Name | Convatec Group PLC | Last Updated | 2025-11-05 |
|---|---|---|---|
| Industry | Medical Instruments & Supplies | Sector | Healthcare |
| Shares in Issue | 1.983 bn | Market Cap | £4.84 bn |
| PE Ratio | 29.59 | Dividend per Share | $0.06 |
| Dividend Yield | 2.11 | Dividend Cover | 1.48 |
| EPS | $0.09 | EPS Growth (%) | 0.20 |
| PEG | 1.64 | DPS Growth (%) | 0.0002 |
| Debt Ratio | 0.3553 | Debt Equity Ratio | 0.7313 |
| Asset Equity Ratio | 2.0823 | Cash Equity Ratio | 0.0528 |
| Quick Ratio | 1.0407 | Current Ratio | 1.95 |
| Price To Book Value | 3.5149 | ROCE | 0 |
Convatec Group PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|---|---|---|---|---|
| Interim | 2025-08-21 | 2025-10-01 | GBP | 0.0140 | |
| Prelim | 2025-04-17 | 2025-05-29 | GBP | 0.0364 | |
| Interim | 2024-08-22 | 2024-10-04 | GBP | 0.0142 | |
| Prelim | 2024-04-25 | 2024-05-23 | GBP | 0.0352 | |
| Interim | 2023-08-17 | 2023-09-28 | GBP | 0.0138 | |
| Prelim | 2023-04-06 | 2023-05-25 | GBP | 0.0366 |
Convatec Group PLC Company Financials
| Assets | 2024 | 2023 | 2022 |
|---|---|---|---|
| Tangible Assets | $570.10 m | $548.50 m | $479.80 m |
| Intangible Assets | $2.10 bn | $2.23 bn | $2.15 bn |
| Investments | $16.90 m | $22.90 m | $30.70 m |
| Total Fixed Assets | $2.72 bn | $2.84 bn | $2.70 bn |
| Stocks | $349.60 m | $396.10 m | $336.90 m |
| Debtors | $301.00 m | $308.80 m | $314.60 m |
| Cash & Equivalents | $64.70 m | $97.60 m | $143.80 m |
| Other Assets | $38.60 m | $38.20 m | $42.70 m |
| Total Assets | $3.52 bn | $3.71 bn | $3.59 bn |
| Liabilities | 2024 | 2023 | 2022 |
|---|---|---|---|
| Creditors within 1 year | $512.30 m | $536.40 m | $533.10 m |
| Creditors after 1 year | $1.31 bn | $1.48 bn | $1.45 bn |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | $1.83 bn | $2.02 bn | $1.98 bn |
| Net assets | $1.69 bn | $1.69 bn | $1.61 bn |
| Equity | 2024 | 2023 | 2022 |
|---|---|---|---|
| Called up share capital | $251.50 m | $251.50 m | $250.70 m |
| Share Premium | $181.00 m | $181.00 m | $165.70 m |
| Profit / Loss | $245.90 m | $167.40 m | $81.90 m |
| Other Equity | $1.69 bn | $1.69 bn | $1.61 bn |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | $1.69 bn | $1.69 bn | $1.61 bn |
| Ratios | 2024 | 2023 | 2022 |
|---|---|---|---|
| Debt Ratio | $0.41 | $0.43 | $0.44 |
| Debt-to-Equity | $0.70 | $0.76 | $0.80 |
| Assets / Equity | 2.0823 | 2.0823 | 2.0823 |
| Cash / Equity | 0.0528 | 0.0528 | 0.0528 |
| EPS | $0.09 | $0.07 | $0.05 |
| Cash Flow | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash from operating activities | $396.20 m | $367.40 m | $281.70 m |
| Cashflow before financing | $132.40 m | $243.40 m | $44.60 m |
| Increase in Cash | -$28.40 m | -$42.30 m | -$303.70 m |
| Income | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | $2.29 bn | $2.14 bn | $2.07 bn |
| Cost of sales | $1.01 bn | $941.80 m | $968.60 m |
| Gross Profit | $1.28 bn | $1.20 bn | $1.10 bn |
| Operating Profit | $324.90 m | $262.70 m | $207.30 m |
| Pre-Tax profit | $245.90 m | $167.40 m | $81.90 m |
Convatec Group PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | Originally spun out of Bristol-Myers Squibb, ConvaTec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue. |
| Latest Interim Date | 29 Jul 2025 |
| Latest Fiscal Year End Date | 26 Feb 2025 |
Convatec Group PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2025-03-19 | Ms. Heather L. Mason | Non-Executive Director |
| 2019-06-28 | Mr. Jesper Ovesen | Non-Executive Director |
| 2019-05-09 | Sir Christopher Charles Gent | Non-Executive Director,Chairman |
| 2022-02-28 | Mr. Rick D. Anderson | Non-Executive Director |
| 2018-02-27 | Mr. Nigel Clerkin | Executive Director,Chief Financial Officer |
| 2023-09-08 | Professor Sten Scheibye | Non-Executive Director |
| 2019-03-31 | Mr. Steven John Holliday | Non-Executive Director,Deputy Chairman |
| 2025-03-19 | Dr. John David Gibson McAdam CBE | Non-Executive Director,Chairman |
| 2025-03-19 | Mr. Brian Michael May | Non-Executive Director |
| 2025-03-19 | Ms. Margaret Ewing | Non-Executive Director,Senior Independent Director |
| 2025-10-27 | Mr. Karim Bitar | Executive Director,Chief Executive Officer |
| 2025-03-19 | Ms. Kimberly S. Lody | Non-Executive Director |
| 2020-08-31 | Dr. Rosalind Catherine Rivaz | Non-Executive Director |
| 2025-10-06 | Ms. Sharon L. O’Keefe | Non-Executive Director |
| 2023-03-22 | Dr. Regina M. Benjamin, M.D. | Non-Executive Director |
| 2019-02-27 | Mr. Paul Moraviec | Executive Director,Chief Executive Officer |
| 2018-07-03 | Mr. Kasim Kutay | Non-Executive Director |
| 2021-12-16 | Mr. Frank Maria Schulkes | Executive Director,Chief Financial Officer |
| 2025-03-19 | Professor Constantin Coussios OBE | Non-Executive Director |
| 2025-09-11 | Mr. Jonny Mason | Executive Director,Chief Executive Officer (Interim) |
Convatec Group PLC Contact Details
| Company Name | ConvaTec Group PLC |
|---|---|
| Address | 23 Forbury Road, 3 Forbury Place, Reading, RG1 3JH |
| Telephone | +44 1189528100 |
| Website | https://www.convatecgroup.com |
Convatec Group PLC Advisors
| Remuneration Consultant | Kepler Associates |
|---|---|
| Phone | +44 2079307730 |
| Fax | +44 2079307733 |
| Stockbroker | UBS Limited |
|---|---|
| Phone | +44 2075678000 |
| Stockbroker | Goldman Sachs International |
|---|---|
| Phone | +44 2077741000 |
| Financial Adviser | Evercore Partners |
|---|---|
| Phone | +44 2076536000 |
| Fax | +44 2076536001 |
| Financial PR Adviser | Finsbury |
|---|---|
| Phone | +44 2072513801 |
| Fax | +44 2073744133 |
| Auditor | Deloitte LLP |
|---|---|
| Phone | +44 2079363000 |
| Fax | +44 2075831198 |
| Registrar | Computershare Investor Services PLC |
|---|---|
| Phone | +44 3707020003 |
| Fax | +44 3707036101 |
| Solicitor | Freshfields Bruckhaus Deringer |
|---|---|
| Phone | +44 2079364000 |
| Fax | +44 2078327001 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine

Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Ceres Power Holdings PLC | 340.00 | 8.70 |
| Trainline PLC | 276.40 | 8.65 |
| Bluefield Solar Income Fund Limited | 78.15 | 8.24 |
| Metro Bank Holdings PLC | 116.24 | 6.64 |
| Lancashire Holdings Limited | 677.00 | 4.80 |
| International Workplace Group PLC | 220.80 | 2.70 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Tp Icap Group PLC | 248.50 | -5.15 |
| Weir Group PLC | 2,796.00 | -2.92 |
| Oxford Biomedica PLC | 662.00 | -2.93 |
| Playtech PLC | 240.50 | -2.83 |
| Raspberry Pi Holdings PLC | 339.20 | -2.81 |
| Allianz Technology Trust PLC | 526.04 | -1.86 |